Back to VA VANGUARD CAPITAL MANAGEMENT LLC
BIAF2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in BIOAFFINITY TECHNOLOGIES INC
Yes. Vanguard Capital Management holds 55,543 shares of BIAF (Bioaffinity Technologies), worth $45,101, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Vanguard Capital Management has held BIAF in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$45,101
Current Shares
55,543
Total Value Change
-$167,629
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of BIAF: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD FIDUCIARY TRUST CO, Schonfeld Strategic Advisors LLC, BlackRock, Inc., STATE STREET CORP